Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

What is the vascepa rebate amount?

See the DrugPatentWatch profile for vascepa

How much is the Vascepa patient rebate?

The manufacturer offers a $75 monthly copay savings card for eligible commercially insured patients. This reduces the out-of-pocket cost at the pharmacy for each 30-day fill.

Who can use the Vascepa savings card?

Patients must have commercial insurance and meet income or coverage restrictions. Government-insured patients (Medicare, Medicaid, Tricare) are generally ineligible. The card is not valid in certain states and cannot be combined with other offers.

When does the Vascepa savings program change?

The $75 limit is the current published amount. Rebate programs can be adjusted or discontinued at any time by the manufacturer, so patients should verify the latest offer directly through the program site before filling a prescription.

How does the Vascepa rebate compare to other omega-3 drugs?

Generic icosapent ethyl versions typically cost less than brand-name Vascepa, and some pharmacies offer their own discount programs. The Vascepa card provides a fixed monthly reduction rather than a percentage-based rebate, which can be more predictable for patients paying high copays.

What happens after the patent expires?

Amarin’s U.S. patents for Vascepa expired in 2022. Multiple generic icosapent ethyl products are now available, often at substantially lower list prices. The manufacturer savings card remains in place for the brand but is less relevant once generics capture most prescriptions.



Other Questions About Vascepa :

how much is vascepa without insurance Does vascepa lower blood pressure when combined with other medications? Can you stop taking vascepa? How do i take vascepa? Are there any limitations to vascepa discounts? Are there any dietary restrictions while using vascepa? What vascepa side effects should i prioritize?